论文信息 - Intermittent versus continuous erlotinib with concomitant modified “XELOX” (q3W) in first‐line treatment of metastatic colorectal cancer - 字舞流文

Intermittent versus continuous erlotinib with concomitant modified “XELOX” (q3W) in first‐line treatment of metastatic colorectal cancer

A. King | A. Ahuja | E. Hui | F. Mo | A. Chan | K. To | B. Ma | S. C. Wong | C. Chan | W. Ho | Stephen L. Chan | W. Lau | A. Poon | Rasalkar D. Dattatray | S. Chan | S. Wong